West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is ...

Ariel Ecton, a budding writer played by Ayo Edebiri who’s one of a handful of journalists selected to visit the compound of ...

C4 Therapeutics shows promise in protein degraders but faces safety concerns and long timelines. Click here to find out why I ...

IAG has earmarked €200 million ($216.5 million) over the next five years for a new venture capital arm to invest in young ...

In order to meet our goals for carbon neutralization by the 2050s, we need environmentally friendly fuels. Catalysts (and ...

Boise State University’s Department of Writing Studies is offering a new Bachelor of Arts in Professional and Public Writing ...

New research on using controlled environment agriculture (CEA) to grow plants with medicinal properties could lead to ...

As previously reported, Guggenheim initiated coverage of ArriVent Biopharma (AVBP) with a Buy rating and $45 price target The late-clinical ...

Last week, semiconductor company Broadcom (AVGO) impressed investors with its upbeat performance for the first quarter of Fiscal 2025 and a ...

Peter Rawlinson stepped down as CEO of the company. However, the company veteran will remain in an advisory role. Lucid plans ...

Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...

Irit Dinur's journey through mathematics and computer science led her to become the first woman professor at the Institute for Advanced Study.